Article Versions Notes

Khetan R, Dharmayanti C, Gillam TA, Kübler E, Klingler-Hoffmann M, Ricciardelli C, Oehler MK, Blencowe A, Garg S, Albrecht H. Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers. 2022; 14(10):2362. https://doi.org/10.3390/cancers14102362

Khetan, Riya, Cintya Dharmayanti, Todd A. Gillam, Eric Kübler, Manuela Klingler-Hoffmann, Carmela Ricciardelli, Martin K. Oehler, Anton Blencowe, Sanjay Garg, and Hugo Albrecht. 2022. "Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines" Cancers 14, no. 10: 2362. https://doi.org/10.3390/cancers14102362

Khetan, R., Dharmayanti, C., Gillam, T. A., Kübler, E., Klingler-Hoffmann, M., Ricciardelli, C., Oehler, M. K., Blencowe, A., Garg, S., & Albrecht, H. (2022). Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers, 14(10), 2362. https://doi.org/10.3390/cancers14102362